Related Experiment Video
Updated: May 27, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1
Simone Lemeer1, Andrej Bluwstein, Zhixiang Wu
1Chair of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, 85354 Freising, Germany.
Abstract:
The receptor tyrosine kinase DDR1 has been implicated in multiple human cancers and fibrosis and is targeted by the leukemia drug Gleevec. This suggests that DDR1 might be a new therapeutic target. However, further insight into the DDR1 signaling pathway is required in order to support its further development. Here, we investigated DDR1 proximal signaling by the analysis of protein-protein interactions using proteomic approaches. All known interactors of DDR1 were identified and localized to specific phosphotyrosine residues on the receptor. In addition, we identified numerous signaling proteins as new putative phosphotyrosine mediated interactors including RasGAP, SHIP1, SHIP2, STATs, PI3K and the SRC family kinases. Most of the new proteins contain SH2 and PTB domains and for all interactors we could directly point the site of interaction to specific phosphotyrosine residues on the receptor. The identified proteins have roles in the early steps of the signaling cascade, propagating the signal from the DDR1 receptor into the cell. The map of phosphotyrosine mediated interactors of DDR1 created in this study will serve as a starting point for functional investigations which will enhance our knowledge on the role of the DDR1 receptor in health and disease. This article is part of a Special Section entitled: Understanding genome regulation and genetic diversity by mass spectrometry.
Insights
Discovering DDR1 signaling pathways is key for cancer and fibrosis therapies. This study maps protein interactions, revealing new targets for drug development against DDR1 receptor tyrosine kinase.
Area of Science:
- Molecular Biology
- Cell Signaling
- Proteomics
Background:
- The receptor tyrosine kinase DDR1 is linked to human cancers and fibrosis.
- DDR1 is a therapeutic target, evidenced by its targeting by Gleevec.
- DDR1 signaling pathway requires further investigation for therapeutic development.
Purpose of the Study:
- To investigate DDR1 proximal signaling.
- To identify DDR1 protein-protein interactions using proteomic approaches.
- To map phosphotyrosine-mediated interactors of DDR1.
Main Methods:
- Proteomic analysis of protein-protein interactions.
- Identification and localization of DDR1 interactors.
- Mass spectrometry for understanding genome regulation.
Main Results:
- All known DDR1 interactors were identified and localized to specific phosphotyrosine residues.
- Numerous new signaling proteins, including RasGAP, SHIP1, SHIP2, STATs, PI3K, and SRC family kinases, were identified as putative interactors.
- Interaction sites were mapped to specific phosphotyrosine residues on the DDR1 receptor.
Conclusions:
- The study provides a comprehensive map of DDR1 phosphotyrosine-mediated interactors.
- This map serves as a foundation for functional studies on DDR1 in health and disease.
- The identified proteins are involved in early signaling events downstream of DDR1.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
IP3/DAG Signaling Pathway
Amplifying Signals via Enzymatic Cascade

